SAN DIEGO, Feb. 2, 2018 /PRNewswire-USNewswire/ — A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists at NYU Langone Health.
The…
